Saturday, September 11
1:00–1:45 PM EDT
Return to the full CEU 2021 program.
Dr. Vaidya is currently the Director of the Center for Adrenal Disorders at Brigham and Women’s Hospital and an Associate Professor at Harvard Medical School. He oversees the multi-disciplinary clinical care of patients with adrenal diseases and runs a translational research program.
His research has helped characterize and redefine the severity spectrum of primary aldosteronism, the optimal approaches to treating primary aldosteronism, the genetics of pheochromocytoma-paraganglioma syndromes, and the systemic consequences of adrenal tumors and hypercortisolism.
Dr. Vaidya is a dedicated educator; he is the director of the pre-clerkship endocrinology curriculum at HMS, he directs the interactive medical case series for The New England Journal of Medicine, and he regularly teaches clinical audiences about updates in adrenal diseases.
Dr. Young is the Tyson Family Endocrinology Clinical Professor and Professor of Medicine in the Mayo Clinic College of Medicine at Mayo Clinic in Rochester, Minn., USA. He is the recipient of multiple education awards and is a past president of the Endocrine Society and past chair of the Division of Endocrinology at Mayo Clinic.
Dr. Young’s clinical research focuses on primary aldosteronism and pheochromocytoma. He has published more than 300 articles on endocrine hypertension and adrenal and pituitary disorders. He has delivered more than 650 presentations at national and international meetings and he has been an invited visiting professor for more than 150 medical institutions.
Lauren Fishbein, MD, PhD, MTR, is an Assistant Professor in Medicine at the University of Colorado School of Medicine in the Division of Endocrinology, Metabolism and Diabetes. She earned an MD, PhD degree from the University of Florida, and completed Internal Medicine Residency at Harvard’s Beth Israel Deaconess Medical Center and Endocrinology Fellowship at the University of Pennsylvania.
Her research and clinical interests are in neuroendocrine tumor genetics. Dr. Fishbein has a strong interest in personalized medicine including understanding the impact of germline predisposition genetics, as well as understanding neuroendocrine tumor development and metastatic disease. Dr. Fishbein is a member of the Endocrine Society’s Annual Meeting Steering Committee and previously served as co-chair of the Trainee and Career Development Core Committee.
